Literature DB >> 19147018

Commissioning of volumetric modulated arc therapy (VMAT).

James L Bedford1, Alan P Warrington.   

Abstract

PURPOSE: Volumetric modulated arc therapy (VMAT) involves the simultaneous use of dynamic multileaf collimator (DMLC) techniques and gantry arcing; appropriate quality assurance is therefore required. This article describes the development and implementation of procedures for commissioning VMAT on a commercial linear accelerator (Elekta PreciseBeam VMAT with MLCi and Beam Modulator heads).
MATERIALS AND METHODS: Tests for beam flatness and symmetry at the variable dose rates required for VMAT were performed. Multileaf collimator (MLC) calibration was investigated using dynamic prescriptions. The cumulative dose delivered by a sliding window aperture was measured and compared with calculated values. Rotational accuracy was evaluated using dynamic prescriptions which required accurate correlated motion of both gantry and MLC leaves. Finally, measured and calculated dose distributions for complete VMAT treatment plans were compared and evaluated.
RESULTS: Beam symmetry was found to be better than 3% down to dose rates of 75 MU/min. MLC calibration provided continuity of dose at match planes of better than 4%, which was comparable to interleaf leakage effects. Integrated sliding window doses were within 3% of those calculated. Tests for rotational accuracy showed uniformity of peripheral dose mostly within +/-4% of local control point dose, or approximately +/-0.2% of total central dose. A two-arc prostate case showed an absolute dose difference between calculations and measurements of less than 3%, with gamma (3% and 3 mm) of better than 95%.
CONCLUSIONS: VMAT has been successfully commissioned and has been introduced into clinical use. The Elekta DMLC has also been shown to be suitable for sliding window delivery.

Entities:  

Mesh:

Year:  2009        PMID: 19147018     DOI: 10.1016/j.ijrobp.2008.08.055

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  55 in total

1.  Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hui-Min Ting; Su-Hua Lo; Yu-Wen Wang; Chiu-Ching Tuan; Fu-Min Fang; Te-Jen Su
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

2.  Multicriteria VMAT optimization.

Authors:  David Craft; Dualta McQuaid; Jeremiah Wala; Wei Chen; Ehsan Salari; Thomas Bortfeld
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

3.  Quality assurance of dynamic parameters in volumetric modulated arc therapy.

Authors:  A Manikandan; B Sarkar; R Holla; T R Vivek; N Sujatha
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

4.  Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.

Authors:  Alice Y Ho; Ase Ballangrud; Guang Li; Gaorav P Gupta; Beryl McCormick; Richard Gewanter; Daphna Gelblum; Melissa Zinovoy; Boris Mueller; Borys Mychalczak; Pinaki Dutta; Karen Borofsky; Preeti Parhar; Marsha Reyngold; Lior Z Braunstein; Mohit Chawla; Kate Krause; Natasha Freeman; Chun Ting Siu; Zachary Cost; Brittany B Arnold; Zhigang Zhang; Simon N Powell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-30       Impact factor: 7.038

5.  Dose verification for respiratory-gated volumetric modulated arc therapy.

Authors:  Jianguo Qian; Lei Xing; Wu Liu; Gary Luxton
Journal:  Phys Med Biol       Date:  2011-07-13       Impact factor: 3.609

6.  Minimum requirements for commissioning and long-term quality assurance of Elekta multi-leaf collimator for volumetric modulated arc therapy.

Authors:  Daisaku Tatsumi; Ryosei Nakada; Akane Yomoda; Kentaro Ishii; Shinichi Tsutsumi; Makoto Inoue; Takao Ichida; Masako N Hosono; Yukio Miki
Journal:  Radiol Phys Technol       Date:  2012-08-14

7.  Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement.

Authors:  J D Fontenot; M L King; S A Johnson; C G Wood; M J Price; K K Lo
Journal:  Br J Radiol       Date:  2011-06-28       Impact factor: 3.039

8.  Commissioning and Acceptance Testing of the existing linear accelerator upgraded to volumetric modulated arc therapy.

Authors:  Ekambaram Varadharajan; Velayudham Ramasubramanian
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-06

9.  Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment.

Authors:  Barbara Dobler; Karin Weidner; Oliver Koelbl
Journal:  Radiat Oncol       Date:  2010-10-25       Impact factor: 3.481

10.  Dose verification of volumetric modulated arc therapy (VMAT) by use of in-treatment linac parameters.

Authors:  Akihiro Haga; Akira Sakumi; Yukari Okano; Saori Itoh; Naoya Saotome; Satoshi Kida; Hiroshi Igaki; Kenshiro Shiraishi; Hideomi Yamashita; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Radiol Phys Technol       Date:  2013-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.